Life and death: how ± degree can break the cold chain | IoT Leaders Podcast

Presented by

Nick Earle, CEO of Eseye and Fred Roe, Vice President of Sales at PharmaWatch

About this talk

When it’s a matter of life or death, the holy grail of 100% connectivity isn’t just a nice-to-have. Storing medical materials, human tissue, vaccines and embryos requires very cold, stable conditions. Monitoring the containers with these material is essential — and there’s no shortcut. Thankfully, IoT empowers industry-leading environmental monitoring companies like PharmaWatch to innovate for clients and patients and make solutions more broadly available. PharmaWatch Vice President of Sales Fred Roe joins the podcast to offer insight into how IoT is shaping the healthcare and pharmaceutical industries, including: - Why tiny increments matter so much to environmental monitoring - How PharmaWatch went from Wi-Fi to Eseye's cellular connectivity in its quest for the holy grail - How Eseye’s AnyNet SMARTconnect™ performed during the 2022 Rogers outage Tune in to learn more about how device intelligence is evolving to offer healthcare organisations big wins.

Related topics:

More from this channel

Upcoming talks (1)
On-demand talks (75)
Subscribers (2184)
As a world leader in IoT connectivity solutions, Eseye helps customers to realise lasting value from global IoT projects. We bring the deep device expertise needed to integrate, manage and optimise IoT connectivity for estates of any scale or complexity. Then seamlessly connect these devices across 190 countries and more than 700 networks. All with near-100% uptime. We see IoT differently. We always start with the device – getting this right is the key to success. Together, we define what good looks like, then build a custom roadmap to deliver IoT right first time. We help customers to navigate every step, from idea to implementation and beyond. This is future-proofed IoT, built on decades of end-to-end delivery for the likes of Amazon, Shell and Costa Coffee. Nobody does IoT better. Find out more at